Accession Number: | 0001367644-23-000105 |
Date: | 2023-05-25 |
Issuer: | EMERGENT BIOSOLUTIONS INC. (EBS) |
Original Submission Date: |
KATKIN KEITH
400 PROFESSIONAL DRIVE
SUITE 400
GAITHERSBURG, MD 20879
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-05-25 | A | 33,847 | a | $0.00 | 42,442 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. these restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. each restricted stock unit represents the right of the reporting person to receive one share of common stock of emergent biosolutions inc., subject to adjustment as provided in the grant agreement. |